Outcomes of Patients (PTS) with Unfavourable, Nonsquamous Cancer of Unknown Primary (CUP) Progressing After Induction Chemotherapy (CTX) in the Global, Open-Label, Phase II Cupisco Study
| dc.contributor.author | Bochtler, T. | |
| dc.contributor.author | Kraemer, A. | |
| dc.contributor.author | Pauli, C. | |
| dc.contributor.author | Duran-Pacheco, G. | |
| dc.contributor.author | Arslan, C. | |
| dc.contributor.author | Bigot, F. | |
| dc.contributor.author | Mileshkin, L. | |
| dc.date.accessioned | 2026-02-25T15:07:31Z | |
| dc.date.available | 2026-02-25T15:07:31Z | |
| dc.date.issued | 2024 | |
| dc.description.sponsorship | F. Hoffmann-La Roche Ltd. | en_US |
| dc.description.sponsorship | F. Hoffmann-La Roche Ltd. | en_US |
| dc.identifier.doi | 10.1016/j.annonc.2024.08.2205 | |
| dc.identifier.issn | 0923-7534 | |
| dc.identifier.issn | 1569-8041 | |
| dc.identifier.uri | https://doi.org/10.1016/j.annonc.2024.08.2205 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14365/8680 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier | en_US |
| dc.relation.ispartof | Annals of Oncology | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.title | Outcomes of Patients (PTS) with Unfavourable, Nonsquamous Cancer of Unknown Primary (CUP) Progressing After Induction Chemotherapy (CTX) in the Global, Open-Label, Phase II Cupisco Study | en_US |
| dc.type | Conference Object | en_US |
| dspace.entity.type | Publication | |
| gdc.author.wosid | Pazo-Cid, Roberto/Aah-3844-2020 | |
| gdc.author.wosid | Mustafa, Özgüroğlu/A-8234-2016 | |
| gdc.author.wosid | Pauli, Chantal/Htt-4689-2023 | |
| gdc.author.wosid | Italiano, Antoine/Jrw-6637-2023 | |
| gdc.collaboration.industrial | true | |
| gdc.description.department | İEÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
| gdc.description.departmenttemp | [Bochtler, T.] Heidelberg Univ, German Canc Ctr DKFZ, Clin Operat Unit Mol Hematol Oncol, Dept Internal Med 5, Heidelberg, Germany; [Bochtler, T.] Heidelberg Univ, German Canc Ctr DKFZ, Dept Med Oncol, Heidelberg, Germany; [Bochtler, T.] Heidelberg Univ Hosp, Natl Ctr Tumor Dis, Heidelberg, Germany; [Kraemer, A.] German Canc Res Ctr, Clin Operat Unit Mol Hematol Oncol, Heidelberg, Germany; [Kraemer, A.] German Canc Res Ctr, Dept Internal Med 5, Heidelberg, Germany; [Kraemer, A.] Heidelberg Univ, Heidelberg, Germany; [Pauli, C.; Moch, H.] Univ Hosp Zurich, Dept Pathol & Mol Pathol, Zurich, Switzerland; [Pauli, C.; Moch, H.] Univ Zurich, Zurich, Switzerland; [Duran-Pacheco, G.; Chalabi, N.] F Hoffmann La Roche Ltd, Global Product Dev Med Affairs, Basel, Switzerland; [Arslan, C.] Izmir Univ Econ Med Point Hosp, Dept Med Oncol, Izmir, Turkiye; [Bigot, F.] Inst Cancerol Ouest, Dept Med Oncol, Angers, France; [Cook, N.] Christie NHS Fdn Trust, Manchester, Lancs, England; [Cook, N.] Univ Manchester, Fac Biol Med & Hlth, Div Canc Sci, Manchester, Lancs, England; [Italiano, A.] Inst Bergonie, Early Phase Trials Unit, Bordeaux, France; [Italiano, A.] Inst Bergonie, Sarcoma Unit, Bordeaux, France; [Losa, F.] ICO Hosp, Hosp St Joan Despi Moises Broggi, Med Oncol Dept, Barcelona, Spain; [Menezes, J.] Ctr Pesquisa Integrado Oncol, Clin Oncol, Porto Alegre, RS, Brazil; [Ma, N.] Genentech Inc, Prod Dev Safety PDS, San Francisco, CA USA; [Ozguroglu, M.] Istanbul Univ Cerrahpasa, Fac Med, Dept Internal Med, Div Med Oncol,Clin Trial Unit, Istanbul, Turkiye; [Pazo Cid, R. A.] Miguel Servet Univ Hosp, Dept Med Oncol, Zaragoza, Spain; [Ross, J. S.] Fdn Med Inc, Pathol Grp, Cambridge, MS USA; [Ross, J. S.] SUNY Upstate Med Univ, Dept Pathol, Urol & Med Oncol, Syracuse, NY USA; [Shiu, K-K.] UCL Canc Inst, Canc Unknown Primary Serv, UCLH Gastrointestinal Oncol Serv, London, England; [Arni, P.] Evang Kliniken Essen Mitte, Dept Med Oncol, Essen, Germany; [Mileshkin, L.] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia | en_US |
| gdc.description.endpage | S297 | en_US |
| gdc.description.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q1 | |
| gdc.description.startpage | S296 | en_US |
| gdc.description.volume | 35 | en_US |
| gdc.description.woscitationindex | Science Citation Index Expanded - Conference Proceedings Citation Index - Science | |
| gdc.description.wosquality | Q1 | |
| gdc.identifier.openalex | W4402565611 | |
| gdc.identifier.wos | WOS:001326612900200 | |
| gdc.index.type | WoS | |
| gdc.openalex.collaboration | International | |
| gdc.openalex.fwci | 0.5845 | |
| gdc.openalex.normalizedpercentile | 0.73 | |
| gdc.virtual.author | Arslan, Çağatay | |
| relation.isAuthorOfPublication | e39c1203-60be-410a-97b3-27cb69d126a9 | |
| relation.isAuthorOfPublication.latestForDiscovery | e39c1203-60be-410a-97b3-27cb69d126a9 | |
| relation.isOrgUnitOfPublication | 7b4bd652-27ef-4beb-a10e-dddd2d65e0fd | |
| relation.isOrgUnitOfPublication | fbc53f3e-d1d3-4168-afd8-e42cd20bddd9 | |
| relation.isOrgUnitOfPublication | e9e77e3e-bc94-40a7-9b24-b807b2cd0319 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 7b4bd652-27ef-4beb-a10e-dddd2d65e0fd |
